In this INSIGHT 2021 talk, Dr. Helena Rogg presents a moving case study on the use of ketamine to treat Borderline Personality Disorder (BPD). A 20-year-old woman with BPD suffered from intense suicidal ideation and excessive self-harm which led to the loss of her leg. She received two doses of ketamine (0,5 mg/kg KG) within one week and both her BDI (‐38%) and BSL‐23 (‐25%) scores were reduced and no self‐injury was reported during 1 month follow‐up. Could ketamine be a new effective treatment for severe BPD?
Many questions remain, join INSIGHT 2023, help us come to real solutions, and shape the future of mental health and human development:
insight-conference.eu/
All INSIGHT 2021 talks and panels are now publicly available on the MIND Community Platform. Just sign up on the network and become part of our community of professionals, students, and friends.
MIND Community Platform: community.mind-foundation.org
INSIGHT 2021 Replays: community.mind-foundation.org...